Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha

Central Nervous System Agents in Medicinal Chemistry

Volumn 10, Issue 3, 2010, Pages 238-246

  Murthy, M R Ven ^a   Ranjekar, Prabhakar K ^b   Ramassamy, Charles ^a,c   Deshpande, Manasi ^d  

^a UNIVERSITÉ LAVAL   (Canada)

^b Bharati Vidyapeeth Deemed University   (India)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

^d BHARATI VIDYAPEETH UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Mitochondria; Oxidative stress; Parkinson's disease

Indexed keywords

APHRODISIAC AGENT; AYURVEDIC DRUG; DIURETIC AGENT; WITHANIA SOMNIFERA EXTRACT;

ACORUS CALAMUS; ARTICLE; AYURVEDA; BACOPA MONNIERI; BRAHMI; CELESTRUS PANNICULATUS; CENTELLA ASIATICA; CONVOLVULUS; DEGENERATIVE DISEASE; FRUIT; GEOGRAPHIC DISTRIBUTION; HERBAL MEDICINE; HISTORY OF MEDICINE; HUMAN; INDIA; JATAMANSI; JYOTISHMATI; LONGEVITY; MANDUKPARNI; MEDICAL RESEARCH; MEDICINAL PLANT; NONHUMAN; NORDOSTACHYS JATAMANSI; PHYTOCHEMISTRY; PLANT GENETICS; PLANT LEAF; PLANT ROOT; SHANKHAPUSHPI; SOUTH ASIA; STRESS; TRADITIONAL MEDICINE; VACHA; WITHANIA SOMNIFERA;

EID: 78649272272     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871524911006030238     Document Type: Article

References (98)

1. Bhatt, A.D. Clinical research on Ayurvedic therapies: myths, realities and challenges. J. Assoc. Physicians India, 2001, 49, 558-562.
2. Subbarayappa, B.V. The root of ancient medicine: a historical outline. J. Biosci., 2001, 26, 135-144.
3. Lodha, R.; Bagga, A. Traditional Indian systems of medicine. Ann. Acad. Med. Singapore, 2000, 29(1), 37-41.
4. Ninivaggi, F.J. Ayurveda: a comprehensive guide to traditional Indian medicine for the West. Praeger Press, 2007, ISBN 0313348375.
5. Tillotson, A.K. The One Earth Herbal Sourcebook: Everything You Need to Know About Chinese and Ayurvedic Herbal Treatments; Kensington Publishing Corp.: New York, NY, USA, 2001.
6. Kulkarni, S.K.; Dhir, A. Withania somnifera: An Indian ginseng. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(5), 1093-1105.
7. Bhatia, P.; Rattan, S.I.S.; Cavallius, J.; Clark, B.F.C. Withania somnifera(Ashwagandha) a so-called rejuvenator inhibits growth and macromolecular synthesis of human cells. Med. Sci. Res., 1987, 15, 515-516.
8. Grandhi, A.; Mujumdar, A.M.; Patwardhan, B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J. Ethnopharmacol., 1994, 44(3), 131-135.
9. Winston, D.; Maimes, S. Adaptogens: Herbs for Strength, Stamina and Stress Relief. Healing Arts Press: Rochester, Vermont, USA, 2007.
10. Panossian, A.G. Adaptogens: a historical overview and perspective. Nat. Pharm, 2003, 1, 19-20.
11. Cui, K.; Luo, X.; Xu, K.; Murthy, M.R.V. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog. Neuropsychopharmacol. Biol. Psychiat., 2004, 28(5), 771-799.
12. Hitchon, C.A.; El-Gabalawy, H. S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther., 2004, 6(6), 265-278.
13. Henrotin, Y.E.; Bruckner, P.; Pujol, J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage, 2003, 11(10), 747-55.
14. Halliwell, B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann. Rheum. Dis., 1995, 54(6), 505-510.
15. Clancy, R. M.; Rediske, J.; Tang, X.; Nijher, N.; Frenkel, S.; Philips, M.; Abramson, S. B. Outside-in signaling in the chondrocyte. Nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/rho A/focal adhesion kinase signaling complex. J. Clin. Invest., 1997, 100(7), 1789-1796.
16. Rees, M. D.; Hawkins, C. L.; Davies, M. J. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J. Am. Chem. Soc., 2003, 125(45), 13719-13733.
17. Rees, M. D.; Hawkins, C. L.; Davies, M. J. Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulfates. Biochem. J., 2004, 381(Pt 1), 175-184.
18. Newkirk, M. M.; Goldbach-Mansky, R.; Lee, J.; Hoxworth, J.; McCoy, A.; Yarboro, C.; Klippel J.; El-Gabalawy H. S. Advanced glycation end-product(AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res. Ther., 2003, 5(2), R82-R90.
19. Gutteridge, J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem., 1995, 41(12 Pt 2), 1819-1828.
20. Yuan, X.; Murthy, M.R.V. Neurotoxins, oxidative stress and regulation of antioxidant enzyme genes in neurons. Curr. Trends Neurol., 2005, 1, 1-20.
21. Olanow, C.W. A radical hypothesis for neurodegeneration. Trends Neurosci., 1993, 16, 439-444.
22. Reiter, R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J., 1995, 9(7), 526-533.
23. Muller, D.P.R. In: Sies, H., Ed.; Neurological disease. Antioxidants in Disease Mechanisms and Therapy. Academic Press: New York, 1997, pp. 557-580.
24. Halliwell, B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging, 2001, 18(9), 685-716.
25. Jellinger, K.A. General aspects of neurodegeneration. J. Neural Transm. Suppl., 2003, 65, 101-144.
26. Annunziato, L.; Amoroso, S.; Pannaccione, A.; Cataldi, M.; Pignataro, G.; D'Alessio, A.; Sirabella, R.; Secondo, A.; Sibaud, L.; Di Renzo, G. F. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol. Lett., 2003, 139(2-3), 125-133.
27. Sastre, J.; Pallardo, F.V.; Vina, J. The role of mitochondrial oxidative stress in aging. Free Radic. Biol. Med., 2003, 35(1), 1-8.
28. Sohal, R.S.; Ku, H.H.; Agarwal, S.; Forster, M.J.; Lal, H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev., 1994, 74(1-2), 121-133.
29. Bowling, A.C.; Mutisya, E.M.; Walker, L.C.; Price, D.L.; Cork, L.C.; Beal, M.F. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem., 1993, 60(5), 1964-1967.
30. Fahn, S.; Cohen, G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol., 1992, 32(6), 804-812.
31. Dawson, T.M.; Dawson, V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science, 2003, 302(5646), 819-822.
32. Hashimoto, M.; Rockenstein, E.; Crews, L.; Masliah, E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromol. Med., 2003, 4(1-2), 21-36.
33. Levesque, G.; Murthy, M.R.V. In: Marwah, J.; Teitelbaum, H., Eds.; Alzheimer's disease: what we have learned from gene analysis. Advances in Neurodegenerative Disorders. Alzheimer's and Aging, Prominent Press: Arizona, 1998, Vol. 2, pp. 49-70.
34. Murthy, M.R.V. In: Marwah, J.; Kanthasamy, A.; Eds. Interactions between chromosome 21 and the rest of the human genome in Down syndrome: role of oxidative stress and antioxidant enzymes. Antioxidants and Free Radicals in Health and Disease. Prominent Press: Arizona, 2001, pp. 213-236.
35. Murthy, M.R.V.; Levesque, G. In: Marwah, J.; Kanthasamy, A.(Eds) Down syndrome: free radicals and antioxidant processes. Antioxidants and Free Radicals in Health and Disease. Prominent Press, Arizona, 2001, 237-260.
36. Bowling, A.C.; Schulz, J.B.; Brown, R.H.J.; Beal, M.F. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem., 1993, 61(6), 2322-2325.
37. Gurney, M.E.; Pu, H.; Chiu, A.Y.; Dal Canto, M.C.; Polchow, C.Y.; Alexander, D.D.; Caliendo, J.; Hentati, A.; Kwon, Y.W.; Deng, H. X.; et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 1994, 264(5166), 1772-1775.
38. Traystman, R.J.; Kirsch, J.R.; Koehler, R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol., 1991, 71(4), 1185-1195.
39. Blomgren, K.; Zhu, C.; Hallin, U.; Hagberg, H. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem. Biophys. Res. Commun., 2003, 304(3), 551-559.
40. Sudha, K.; Rao, A. V.; Rao, A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta., 2001, 303(1-2), 19-24.
41. Gonzalez, M.E.; Lorigados, L.M.; Morales, L.; Riveron, G.; Bauza, J.Y. Oxidative stress markers in surgically treated patients with refractory epilepsy. Clin. Biochem., 2007, 40(5-6), 292-298.
42. Verrotti, A.; Scardapane, A.; Franzoni, E.; Manco, R.; Chiarelli, F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res., 2008, 78(2-3), 171-177.
43. Royes, M.; Fighera, A.; Furian, A.F.; Oliveira, M.S.; Fiorenza, N.G.; Petry, J.C.; Coelho, R.C.; Mello, C.F. The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: An electroencephalographic and neurochemical study. Epilepsy Res., 2007, 73(3), 228-237.
44. Akarsu, S.; Yilmaz, S.; Ozan, S.; Kurt, A.; Benzer, F.; Gurgoze, M.K. Effects of febrile and afebrile seizures on oxidant state in children. Pediatr. Neurol., 2007, 36(5), 307-311.
45. Tsai, G.; Goff, D.C.; Chang, R.W.; Flood, J.; Baer, L.; Coyle, J.T. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am. J. Psychiat., 1998, 155(9), 1207-1213.
46. Kuczenski, J.B.; Niculescu, R.; Alexander, B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs, 2003, 17(1), 47-62.
47. Kovacic, P.; Cooksy, A.L. Unifying mechanisms or toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. Med. Hypotheses, 2005, 64(2), 357-366.
48. Chao, J.; Nestler, E.J. Molecular neurobiology of drug addiction. Annu. Rev. Med., 2004, 55, 113-132.
49. Masood, A.; Nadeem, A.; Mustafa, S.J.; O'Donnell, J.M. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther., 2008, 326(2), 369-379.
50. Hovatta, I.; Tennant, R.S.; Helton, R. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature, 2005, 438(7068), 662-666.
51. Liu, J.; Head, E.; Gharib, A.M.; Yuan, W.; Ingersoll, R.T.; Hagen, T.M.; Cotman, C.W.; Ames, B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. USA, 2002, 99(4), 2356-2361.
52. Cui, X.; Zuo, P.; Zhang, Q.; Li, X.; Hu, Y.; Long, J.; Packer, L.; Liu, J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative stress. J. Neurosci. Res., 2006, 84(3), 647-654.
53. Silva, R.H.; Abílio, V.C.; Takatsu, A.L.; Kameda, S.R.; Grassl, C.; Chehin, A.B.; Medrano, W.A.; Calzavara, M.B.; Registro, S.; Andersen, M.L.; Machado, R.B.; Carvalho, R.C.; Ribeiro Rde, A.; Tufik, S.; Frussa-Filho, R. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology, 2004, 46(6), 895-903.
54. Lavie, L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med. Rev., 2003, 7(1), 35-51.
55. Choudhary, M.I.; Yousuf, S.; Nawaz, S.A.; Ahmed, S. Cholinesterase inhibiting withanolides from Withania somnifera. Chem. Pharm. Bull.(Tokyo), 2004, 52(11), 1358-1361.
56. Choudhary, M.I.; Nawaz, S.A.; ul-Haq, Z.; Lodhi, M.A.; Ghayur, M.N.; Jalil, S.; Riaz, N.; Yousuf, S.; Malik, A.; Gilani, A.H.; ur-Rahman, A. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem. Biophys. Res. Commun., 2005, 334(1), 276-287.
57. Riaz, N.; Malik, A.; Aziz-ur-Rehman; Nawaz, S.A.; Muhammad, P.; Choudhary, M. I. Cholinesterase-inhibiting withanolides from Ajuga bracteosa. Chem. Biodivers., 2004, 1(9), 1289-1295.
58. Khattak, S.; Saeed-Ur-Rehman; Shah, H.U.; Khan, T.; Ahmad, M. In vitro enzyme inhibition activities of crude ethanolic extracts derived from medicinal plants of Pakistan. Nat. Prod. Res., 2005, 19(6), 567-571.
59. Vinutha, B.; Prashanth, D.; Salma, K.; Sreeja, S.L.; Pratiti, D.; Padmaja, R.; Radhika, S.; Amit, A.; Venkateshwarlu, K.; Deepak, M. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J. Ethnopharmacol., 2007, 109(2), 359-363.
60. Nagashayana, N.; Sankarankutty, P.; Nampoothiri, M.R.; Mohan, P.K.; Mohanakumar, K. P. Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease. J. Neurol. Sci., 2000, 176, 124-127. Comment in: J. Neurol. Sci., 2001, 184(1), 89-92.
61. Ahmad, M.; Saleem, S.; Ahmad, A.S.; Ansari, M.A.; Yousuf, S.; Hoda, M.N.; Islam, F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol., 2005, 24(3), 137-47.
62. Sankar, S.R.; Manivasagam, T.; Krishnamurti, A.; Ramanathan, M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol. Biol. Lett., 2007, 12(4), 473-481.
63. Tohda, C.; Kuboyama, T.; Komatsu, K. Dendrite extension by methanol extract of Ashwagandha(roots of Withania somnifera) in SK-N-SH cells. Neuroreport, 2000, 11(9), 1981-1985.
64. Zhao, J.; Nakamura, N.; Hattori, M.; Kuboyama, T.; Tohda, C.; Komatsu, K. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem. Pharm. Bull.(Tokyo), 2002, 50(6), 760-765.
65. Kuboyama, T.; Tohda, C.; Komatsu, K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br. J. Pharmacol., 2005, 144(7), 961-971.
66. Tohda, C.; Kuboyama, T.; Komatsu, K. Search for natural products related to regeneration of the neuronal network. Neurosignals, 2005, 14(1-2), 34-45.
67. Kuboyama, T.; Tohda, C.; Komatsu, K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur. J. Neurosci., 2006, 23(6), 1417-1426.
68. Bhattacharya, S.K.; Bhattacharya, A.; Sairam, K.; Ghosal, S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine, 2000, 7(6), 463-469.
69. Shah, P.C.; Trivedi, N.A.; Bhatt, J.D.; Hemavathi, K.G. Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugs. Indian J. Physiol. Pharmacol., 2006, 50(4), 409-415.
70. Nair, V.; Arjuman, A.; Gopalakrishna, H.N.; Nandini, M. Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice. Phytother. Res., 2008, 22(2), 243-246.
71. Nair, V.; Arjuman, A.; Dorababu, P.; Gopalakrishna, H.N.; Chakradhar Rao, U.; Mohan, L. Effect of NR-ANX-C(a polyherbal formulation) on haloperidol induced catalepsy in albino mice. Indian J. Med. Res., 2007, 126(5), 480-484.
72. Kumar, A.; Kulkarni, S.K. Effect of BR-16A(Mentat), a polyherbal formulation on drug-induced catalepsy in mice. Indian J. Exp. Biol., 2006, 44(1), 45-48.
73. Naidu, P.S.; Singh, A.; Kulkarni, S.K. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother. Res., 2006, 20(2), 140-146.
74. Naidu, P.S.; Singh, A.; Kulkarni, S.K. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action. J. Med. Food, 2003, 6(2), 107-114.
75. Bhattacharya, S. K.; Bhattacharya, D.; Sairam, K.; Ghosal, S. Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia. Phytomedicine, 2002, 9(2), 167-170.
76. Chaudhary, G.; Sharma, U.; Jagannathan, N.R.; Gupta, Y.K. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin. Exp. Pharmacol. Physiol., 2003, 30(5-6), 399-404.
77. Adams, J. D. Jr; Yang, J.; Mishra, L.C.; Singh, B.B. Effects of ashwagandha in a rat model of stroke. Altern. Ther. Health Med., 2002, 8(5), 18-19.
78. Parihar, M.S.; Chaudhary, M.; Shetty, R.; Hemnani, T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J. Clin. Neurosci., 2004, 11(4), 397-402.
79. Parihar, M. S.; Hemnani, T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Biosci., 2003, 28(1), 121-128.
80. Jain, S.; Shukla, S. D.; Sharma, K.; Bhatnagar, M. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother. Res., 2001, 15(6), 544-548.
81. Shukla, S.D.; Jain, S.; Sharma, K.; Bhatnagar, M. Stress induced neuron degeneration and protective effects of Semecarpus anacardium Linn. and Withania somnifera Dunn. in hippocampus of albino rats: an ultrastructural study. Indian J. Exp. Biol., 2000, 38(10), 1007-1013.
82. Gupta, S.K.; Dua, A.; Vohra, B.P. Withania somnifera(Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metabol. Drug Interact., 2003, 19(3), 211-222.
83. Singh, A.; Naidu, P.S.; Gupta, S.; Kulkarni, S.K. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food, 2002, 5(4), 211-220.
84. Dhuley, J.N. Nootropic-like effect of ashwagandha(Withania somnifera L.) in mice. Phytother. Res., 2001, 15(6), 524-528.
85. Kumar, A.; Kalonia, H. Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleepdisturbed mice(Grid over water suspended method). Indian J. Exp. Biol., 2007, 45(6), 524-528.
86. Ilayperuma, I.; Ratnasooriya, W.D.; Weerasooriya, T.R. Effect of Withania somnifera root extract on the sexual behaviour of male rats. Asian J. Androl., 2002, 4(4), 295-298.
87. Lizano, S.; Domont, G.; Perales, J. Natural phospholipase A(2) myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon, 2003, 42(8), 963-977.
88. Deepa, M.; Veerabasappa Gowda, T. Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch. Biochem. Biophys., 2002, 408(1), 42-50.
89. Machiah, D. K.; Gowda, T.V. Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera. Biochimie, 2006, 88(6), 701-710.
90. Machiah, D.K.; Girish, K.S.; Gowda, T.V. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2006, 143(2), 158-161.
91. Bhattacharya, S.K.; Bhattacharya, A.; Chakrabarti, A. Adaptogenic activity of Siotone, a polyherbal formulation of Ayurvedic rasayanas. Indian J. Exp. Biol., 2000, 38(2), 119-128.
92. Bhattacharya, A.; Ghosal, S.; Bhattacharya, S. K. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J. Ethnopharmacol., 2001, 74(1), 1-6.
93. Bhattacharya, A.; Muruganandam, A.V.; Kumar, V.; Bhattacharya, S. K. Effect of poly herbal formulation, EuMil, on neurochemical perturbations induced by chronic stress. Indian J. Exp. Biol., 2002, 40(10), 1161-1163.
94. Bhattacharya, S.K.; Muruganandam, A.V. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol. Biochem. Behav., 2003, 75(3), 547-555.
95. Muruganandam, A.V.; Kumar, V.; Bhattacharya, S. K. Effect of poly herbal formulation, EuMil, on chronic stress-induced homeostatic perturbations in rats. Indian J. Exp. Biol., 2002, 40(10), 1151-1160.
96. Singh, B.; Gupta, D.K.; Chandan, B.K. Adaptogenic activity of a glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaertn. Phytomedicine, 2001, 8(4), 283-291.
97. Singh, B.; Chandan, B.K.; Gupta, D.K. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera Dun.(Part II). Phytother. Res., 2003, 17(5), 531-536.
98. Kaur, P.; Sharma, M.; Mathur, S.; Tiwari, M.; Divekar, H.M.; Kumar, R.; Srivastava, K. K.; Chandra, R. Effect of 1-oxo-5beta, 6beta-epoxy-witha-2-ene-27-ethoxy-olide isolated from the roots of Withania somnifera on stress indices in Wistar rats. J. Altern. Complement. Med., 2003, 9 (6), 897-907.